To be the partner of choice Straumann Gilbert Achermann, CEO Helvea Swiss Equities Conference 11 January 2008, Bad Ragaz
Table of contents 1. A snapshot of Straumann 2. Financials 3. Markets and opportunities 4. Innovation, trends and outlook STRAUMANN 2
Straumann comprehensive product offering BU Surgical BU Regenerative BoneCeramic Emdogain Membrane BU Prosthetics synocta Solid abutment Custom abutment LOCATOR Scanners & software Precision production State of the art ceramics STRAUMANN 3
A unique dental partner offering a comprehensive product portfolio Crowns + bridges Abutments Regeneratives Implants Implant-based Conventional STRAUMANN 4
Represented in 60+ countries through a broad network of subsidiaries and distributors e Number of own subsidiaries has risen from 12 (1998) to 20 STRAUMANN 5
Latest network additions Subsidiaries inaugurated in Osaka (July 2007), Seoul (August 2007) and opened local branch office in Budapest (January 2008) Direct access to customers in Asia s two largest markets, collectively worth up to CHF 500m 1 With a dentist population of 5000 dentists, Hungary is one of the most attractive emerging markets in Eastern Europe and the first to be served directly by Straumann 1 STRAUMANN Based on Millennium 2007 data 6
Worldwide production locations Andover (US): Implant component production Malmö (S): Regenerative products e Leipzig (D): CAD/CAM milling Gräfelfing (D): CAD/CAM milling, scanner production Arlington (US): CAD/CAM milling Villeret (CH): Implant component production STRAUMANN 7
A simple clear vision To be the partner of choice in implant, restorative and regenerative dentistry STRAUMANN 8
Table of contents A snapshot of Straumann Financials Markets and opportunities Innovation, trends and outlook STRAUMANN 9
Evidence of opportunity and operational leverage Key figures, Historical performance Sales & profits in CHF m 600 500 CAGR 21.6% 21.4% 400 300 200 100 23.6% 26.2% 0 2002 2003 2004 2005 2006 Sales Gross profit EBIT Net profit STRAUMANN 10
Europe and North America largest sales regions Nine months 2007 - Net revenue by region Asia/Pacific CHF 56m +31.5% growth 3% RoW CHF 15m +71.8% growth 11% North America CHF 114m +13.8% LC growth 2 22% 64% Europe CHF 334m +16.7% LC growth Total Net Revenue: CHF 519m +16.5 in LC 1 No Biora sales in US since early 2007; non-regenerative business grew double digit in the first nine months STRAUMANN 2 US growth in local currencies excluding the effect of the Biora import ban 11
Margins improved at all levels CHF million FY 2006* H1 2006 H1 2007 EBITDA 108.0 126.6 EBITDA margin in % 35.4 EBIT 91.4 EBIT margin in % 29.9 36.0 107.8 30.7 Net profit 70.9 94.9 Net profit margin in % 23.2 27.0 Operating Cash Flow 59.5 92.6 Operating Cash Flow +56% Net profit +34% STRAUMANN 12
Table of contents A snapshot of Straumann Financials Markets and opportunities Innovation, trends and outlook STRAUMANN 13
Our substitution technologies Treatment Manufacturing Materials Crowns and bridges Traditional manufacture Metals Collagen membranes Dental implants CAD/CAM prosthetics Ceramics Hydrogel membranes STRAUMANN 14
Europe and North America remain core markets for implants 2006 global dental implant market by region APAC North America 19% BRIC 29% 7% 45% Europe in CHF bn +17% 5.4 4.7 0.5 4.0 0.4 1.0 3.3 0.3 0.9 2.9 0.2 0.7 1.8 0.2 0.6 1.5 0.5 1.3 1.0 0.9 1.3 1.5 1.7 1.9 2.1 CAGR 06-10 24% 17% 21% 13% 2006 2007 2008 2009 2010 BRIC (BR, RU, IN, CN) APAC (AU, JP, KR) North America (US, CA) Europe (DE, IT, ES, UK, SE, CH, FR) STRAUMANN Source: Millennium 2006 15
Straumann in firm number two position globally - number one in Europe Dental implant market* 2006 100% = 2.9 CHF bn Others 33% 24% Nobel Biocare Dentsply 6% 8% Zimmer 18% Straumann 11% Biomet / 3i STRAUMANN * DE, IT, ES, FR, SE, UK, CH, US, CA, AU, JP, KR, BR, RU, IN, CN; Straumann sales in countries other than those listed here have been excluded 16 Source: Millennium
CAD/CAM tooth restoration market highly attractive Straumann with etkon very well positioned Estimated global market 2005 Crown + bridge prosthetics (USD 3.1 bn) 75-80% 20-25% 40% Up to 25% (USD 600-800 million) of the overall crown and bridge prosthetics market is CAD/CAM based Ceramics make up 40-75% of CAD/CAM restorations in developed countries Conventional and implant-based prosthetics without abutments Customized crowns/bridges (CAD/CAM) STRAUMANN Source: GfK, Straumann estimates 17
In total CHF >4 bn for Straumann to address - Prosthetics will be major future growth driver Dental implant market 100% = CHF 2.9 bn Leading share: >45% CAD/CAM prosthetics market 100% = CHF 0.9 bn Foot-hold share: <5% Dental regeneration market 100% = CHF 0.3 bn 26% 9% Leading share: >75% 60% 40% 65% Tissue level Straumann share in tissue level Bone level Straumann very strong in tissue level segment. New bone level implant to unlock large market potential CAD/CAM prosthetics Straumann share in CAD/CAM With etkon, Straumann has gained a foot-hold in the CAD/CAM prosthetics market Foot-hold share: <5% Perio. tissue regeneration Straumann share in tissue regen Bone graft materials Straumann share in bone graft Membrane Straumann has built a leading position in periodontal tissue regeneration STRAUMANN Source: Millennium, Straumann estimates 18
Table of contents A snapshot of Straumann Financials Markets and opportunities Innovation and trends STRAUMANN 19
Bone-level implant a key launch to offer implant solutions to all dentists Tissue level Pioneered by Straumann The most successful single system Microgap vertically offset from bone, respecting biological width and preserving bone One- and two-stage procedures possible Bone level >50% of all implants placed Microgap at bone level One- and two-stage procedures possible Ease of use and Esthetics considered by many dentists as superior STRAUMANN 20
A great opportunity for Straumann Dental implant placement at tissue vs. bone level Regional split Implant choice is driven mainly by user preference 55% 70% 55% Bone level popularity varies by region 45% 30% 45% The US is particularly attractive for the Straumann Bone Level Implant Europe US APAC Soft tissue level Bone level STRAUMANN 21
The new generation Straumann Bone Level Implant Introducing confidence at bone level Consistent Emergence Profiles TM Matching geometries Soft tissue management SLActive surface Fast healing Higher security CrossFit TM Connection Precise tight fit Easy handling Bone Control Design TM Bone preservation Tissue stability STRAUMANN 22
Confidence based on science 2 pre-clinical studies, very promising results >1500 implants now clinically documented in pilot-, multi-center-, and non-interventional studies; cases documented for >12 months >15 clinical studies supporting SLActive surface STRAUMANN 23
Straumann tomorrow Strategic priorities and ambitions Become a true solution provider in implant, restorative and regenerative dentistry Differentiate through meaningful innovation and added value Defend tissue-level segment, gain ground in the bone-level segment, drive CAD/CAM-franchise and leverage regenerative portfolio Maintain lead in Europe, accelerate North American growth, integrate/leverage Asian distribution, explore opportunities in BRIC countries Deliver above-market growth with increasing underlying profitability in a sustainable manner STRAUMANN 24
Questions & answers Calendar of upcoming events 07 February 2008 Full Year results 2007 18-20 February 2008 European Road Show 28-29 February 2008 U.S. Road Show 28 April 2008 First Quarter revenues 2008 07 August 2008 First Half results 2008 30 October 2008 Nine Month revenues 2008 Detailed calendar on www.straumann.com STRAUMANN 25